BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pathak P, Naumovich V, Grishina M, Shukla PK, Verma A, Potemkin V. Quinazoline based 1,3,5-triazine derivatives as cancer inhibitors by impeding the phosphorylated RET tyrosine kinase pathway: Design, synthesis, docking, and QSAR study. Arch Pharm (Weinheim) 2019;352:e1900053. [PMID: 31380598 DOI: 10.1002/ardp.201900053] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Dong G, Jiang Y, Zhang F, Zhu F, Liu J, Xu Z. Recent updates on 1,2,3‐, 1,2,4‐, and 1,3,5‐triazine hybrids (2017–present): The anticancer activity, structure–activity relationships, and mechanisms of action. Archiv der Pharmazie 2022. [DOI: 10.1002/ardp.202200479] [Reference Citation Analysis]
2 Mandal AK, Paudel S, Pandey A, Yadav P, Pathak P, Grishina M, Jaremko M, Emwas A, Khalilullah H, Verma A. Guava Leaf Essential Oil as a Potent Antioxidant and Anticancer Agent: Validated through Experimental and Computational Study. Antioxidants 2022;11:2204. [DOI: 10.3390/antiox11112204] [Reference Citation Analysis]
3 Ramesh P, Veerappapillai S. Designing Novel Compounds for the Treatment and Management of RET-Positive Non-Small Cell Lung Cancer-Fragment Based Drug Design Strategy. Molecules 2022;27:1590. [PMID: 35268691 DOI: 10.3390/molecules27051590] [Reference Citation Analysis]
4 Maliszewski D, Drozdowska D. Recent Advances in the Biological Activity of s-Triazine Core Compounds. Pharmaceuticals 2022;15:221. [DOI: 10.3390/ph15020221] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
5 Pathak M, Pathak P, Khalilullah H, Grishina M, Potemkin V, Kumar V, Majee R, Ramteke PW, Abdellattif MH, Shahbaaz M, Verma A. Green synthesis of silver nanoformulation of Scindapsus officinalis as potent anticancer and predicted anticovid alternative: Exploration via experimental and computational methods. Biocatalysis and Agricultural Biotechnology 2021;35:102072. [DOI: 10.1016/j.bcab.2021.102072] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
6 Pathak P, Novak J, Shukla PK, Grishina M, Potemkin V, Verma A. Design, synthesis, antibacterial evaluation, and computational studies of hybrid oxothiazolidin-1,2,4-triazole scaffolds. Arch Pharm (Weinheim) 2021;354:e2000473. [PMID: 33656194 DOI: 10.1002/ardp.202000473] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Bhujbal SP, Keretsu S, Cho SJ. Molecular Modelling Studies on Pyrazole Derivatives for the Design of Potent Rearranged during Transfection Kinase Inhibitors. Molecules 2021;26:691. [PMID: 33525725 DOI: 10.3390/molecules26030691] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
8 Hu J, Zhang Y, Tang N, Lu Y, Guo P, Huang Z. Discovery of novel 1,3,5-triazine derivatives as potent inhibitor of cervical cancer via dual inhibition of PI3K/mTOR. Bioorg Med Chem 2021;32:115997. [PMID: 33440319 DOI: 10.1016/j.bmc.2021.115997] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
9 Pathak M, Pathak P, Rimac H, Grishina M, Bagale U, Kumar V, Rahul Majee, Vladimir Potemkin, Verma A. Attenuation of hepatic and breast cancer cells by Polygonatum verticillatum embedded silver nanoparticles. Biocatalysis and Agricultural Biotechnology 2020;30:101863. [DOI: 10.1016/j.bcab.2020.101863] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
10 Pathak P, Naumovich V, Grishina M, Potemkin V. The study of EGFR-ligand complex electron property relationship with biological activity. J Biomol Struct Dyn 2022;40:375-88. [PMID: 32897174 DOI: 10.1080/07391102.2020.1813629] [Reference Citation Analysis]
11 Maraghelli D, Giusti F, Marini F, Brandi ML. Bone tissue and mineral metabolism in hereditary endocrine tumors: clinical manifestations and genetic bases. Orphanet J Rare Dis 2020;15:102. [PMID: 32326947 DOI: 10.1186/s13023-020-01380-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
12 Pathak P, Shukla PK, Naumovich V, Grishina M, Verma A, Potemkin V. 1,2,4‐Triazole‐conjugated 1,3,4‐thiadiazole hybrid scaffolds: A potent ameliorant of carrageenan‐induced inflammation by lessening proinflammatory mediators. Arch Pharm Chem Life Sci 2019;353:1900233. [DOI: 10.1002/ardp.201900233] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]